Targeting <i>Mycobacterium tuberculosis</i> Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors
作者:Matthew R. Bockman、Alvin S. Kalinda、Riccardo Petrelli、Teresa De la Mora-Rey、Divya Tiwari、Feng Liu、Surendra Dawadi、Madhumitha Nandakumar、Kyu Y. Rhee、Dirk Schnappinger、Barry C. Finzel、Courtney C. Aldrich
DOI:10.1021/acs.jmedchem.5b00719
日期:2015.9.24
Mycobacterium tuberculosis (Mtb), responsible for second leading cause of mortality among infectious diseases worldwide. Mycobacterial biotin protein ligase (MtBPL) is an both latent and symptomatic tuberculosis (TB), remains the essential enzyme in Mtb and regulates lipid metabolism through the post-translational biotinylation of acyl coenzyme A carboxylases. We report the synthesis and evaluation of a systematic series of potent nucleoside-based inhibitors of MtBPL that contain modifications to the ribofuranosyl ring of the nucleoside. All compounds were characterized by isothermal titration calorimetry (ITC) and shown to bind potently with K(D)s <= 2 nM. Additionally, we obtained high-resolution cocrystal structures for a majority of the compounds. Despite fairly uniform biochemical potency, the whole-cell Mtb activity varied greatly with minimum inhibitory concentrations (MIC) ranging from 0.78 to >100 mu M. Cellular accumulation studies showed a nearly 10-fold enhancement in accumulation of a C-2'-alpha analogue over the corresponding C-2'-beta analogue, consistent with their differential whole-cell activity.